WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

The therapeutic efficacy of an experimental antiviral agent, WIN 54954, was evaluated in a mouse model in which infection by coxsackievirus B4 (CVB4) strain E2 was followed by diabetes mellitus. Male CD1 mice (age, 5 weeks) were inoculated with 10(4) PFU of CVB4. WIN 54954 was administered orally vi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	See, D M, Tilles, J G
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1993
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188025/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8215268/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.8.1593
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!